Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Vir Biotechnology, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $122 Billion
- Q2 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 49,910 shares of VIR stock, worth $312,935. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,910
Previous 38,290
30.35%
Holding current value
$312,935
Previous $248,000
1.21%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VIR
# of Institutions
245Shares Held
109MCall Options Held
350KPut Options Held
150K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$105 Million0.67% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$82.9 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL12.9MShares$81 Million34.47% of portfolio
-
State Street Corp Boston, MA5.25MShares$32.9 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $832M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...